Table 1 Clinical characteristics of patients enrolled in this study
Characteristics N (%) | All (N = 138) | TBP (N = 82) | MPE (N = 35) | non-TB infection (N = 21) | |
|---|---|---|---|---|---|
Age | Median [range], y | 58 [19–92] | 48.5 [19–92] | 65 [28–85] | 62 [25–85] |
Sex | Female | 43 (31.2) | 21 (25.6) | 14 (40.0) | 8 (38.1) |
Male | 95 (68.8) | 61 (74.4) | 21 (60.0) | 13 (61.9) | |
WBC | Low | 3 (2.2) | 3 (3.7) | 0 (0) | 0 (0) |
Normal | 123 (89.1) | 72 (87.87) | 32 (91.4) | 19 (90.5) | |
High | 8 (5.8) | 4 (4.9) | 2 (5.7) | 2 (9.5) | |
Unknown | 4 (2.9) | 3 (3.7) | 1 (2.9) | 0 (0) | |
PCT | Low | 6 (4.3) | 4 (4.9) | 0 (0) | 2 (9.5) |
Normal | 105 (76.1) | 61 (74.4) | 31 (88.6) | 13 (61.9) | |
High | 23 (16.7) | 14 (17.1) | 3 (8.6) | 6 (28.6) | |
Unknown | 4 (2.9) | 3 (3.7) | 1 (2.9) | 0 (0) | |
CRP | Normal | 26 (18.8) | 10 (12.2) | 11 (31.4) | 5 (23.8) |
High | 109 (79.0) | 70 (85.4) | 23 (65.7) | 16 (76.2) | |
Unknown | 3 (2.2) | 2 (2.4) | 1 (2.9) | 0 (0) | |
Underlying diseases* | Not reported | 54 (39.1) | 38 (46.3) | 12 (34.3) | 4 (19.0) |
Diabetes | 20 (14.5) | 9 (11.0) | 7 (20.0) | 4 (19.0) | |
Hypertension | 33 (23.9) | 9 (11.0) | 15 (42.9) | 9 (42.9) | |
Cardiovascular disease | 6 (4.3) | 2 (2.4) | 1 (2.9) | 3 (14.3) | |
Liver disease | 21 (15.2) | 15 (18.3) | 2 (5.7) | 4 (19.0) | |
Renal disease | 5 (3.6) | 4 (4.9) | 1 (2.9) | 0 (0) | |
Hyperuricemia | 20 (14.5) | 16 (19.5) | 1 (2.9) | 3 (14.3) | |
Hyperlipidemia | 9 (6.5) | 5 (6.1) | 4 (11.4) | 0 (0) | |
Respiratory failure | 4 (2.9) | 3 (3.7) | 1 (2.9) | 0 (0) | |
COPD | 2 (1.4) | 1 (1.2) | 0 (0) | 1 (4.8) | |
Hyperbilirubinemia | 2 (1.4) | 1 (1.2) | 0 (0) | 1 (4.8) | |
Hypercholesterolemia | 1 (0.7) | 0 (0) | 0 (0) | 1 (4.8) | |